Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Advances in the clinical diagnosis, prognosis, and individualized treatment of Multiple Sclerosis
Submission status
Open
Submission deadline
Multiple Sclerosis is a chronic degenerative disease of the central nervous system characterized by inflammatory demyelination and axonal transection. There is no single test for diagnosing Multiple Sclerosis, yet an early and accurate diagnosis, which is itself a challenging task, is very important for the implementation of treatment or lifestyle changes to slow the course of the disease. Diagnosis is usually based on multiple sources of information, including the individual’s clinical history and presentation, imaging of the brain or spinal cord, and blood and cerebrospinal fluid analyses. Advances in the clinical diagnosis and prognosis of the disease are critical for the development of effective individualized treatments for relapses, symptom and pain management, and perhaps even halting the progression of Multiple Sclerosis. This Collection welcomes original research articles from Psychology, Neurology, Neuroscience, Radiology, and Immunology, among others, reporting advances in the clinical diagnosis, prognosis, and individualized treatment of Multiple Sclerosis, as well as its diagnosis and treatment.